Integration of human papillomaviruses (HPVs) into the host genome is considered to be an early and important event in HPV-linked cervical carcinogenesis. Consequently, the viral DNA potentially becomes a target for cellular control mechanisms normally acting on the corresponding integration site. Besides resulting position effects, host-specific DNA methylation may play a functional role in HPV gene regulation. To elucidate the influence of such a kind of epigenetic modification on viral transcription, in vitro methylation studies on HPV-18 upstream regulatory region (URR)-controlled reporter plasmids were carded out. Selective methylation of the viral URR results in a down-regulation of the transcriptional activity, which can be attributed to nonrandom distribution of methyl-acceptor sites clustered within the constitutive enhancer region. In vivo competition experiments show that suppression is not directly mediated by steric hindrance of methyl residues with transcription factors, but rather is due to the association with methyl-CpG DNA-binding proteins. Using a restriction enzyme accessibility assay on both the DNA and chromatin levels, it could be demonstrated that, in vivo, extensively methylated viral DNA is nucleosomally organized, characteristic of transcriptionally inactive chromatin. These data suggest that DNA methylation is an important regulatory pathway in the modulation of HPV expression and as a consequence the proliferation rate of virus-infected cells.
Introduction
It has been well documented that particular types of human papillomaviruses (e.g. are involved in the development of cervical cancer (for review, see zur Hausen, 1989) . Detailed investigation of different levels of viral gene expression during the vegetative cycle is presently hampered by the lack of a permissive in vitro system for the propagation of infectious virus. Most studies depend on DNA transfections in appropriate cell systems or in cervical carcinoma cells, recultivated from primary biopsies, in order to analyse cis-and trans-acting virus-host cell interactions and their influence on HPV transcription in premalignant or malignant cells.
DNA-mediated gene transfer experiments have revealed that the expression of the open reading frames (ORFs) E6 and E7 is necessary and sufficient to immortalize primary human keratinocytes (Mfinger et al., 1989) . This is consistent with the finding that the corresponding ORFs are well conserved in both fresh biopsy materials and cell lines derived therefrom, implying a still functional selection pressure on E6/E7 transcription even in malignant cells (Schwarz et al., 1985; Yee et al., 1985) .
HPV-16/-18 infection and DNA persistence, however,
are not sufficient to transform human keratinocytes malignantly (Dtirst et al., 1987; Pirisi et al., 1987) , indicating that additional modifications are needed to deregulate an evidently balanced equilibrium of hostvirus interaction during latency (zur Hausen, 1986 (zur Hausen, , 1991b ). An important step towards malignant progression is presumably the recombination between the viral DNA and host cellular sequences. In preneoplastic cells, HPV-16/-18 commonly persist as extrachromosomal elements (Dtirst et al., 1985) , whereas the DNA is found to be randomly integrated in the majority of cervical cancers (Choo et al., 1987) . Integration seems to be an early event in HPV-linked carcinogenesis (SchneiderMaunoury et al., 1987) leading regularly to a disruption of the E20RF and to the loss of the corresponding protein, which negatively regulates the upstream regulatory region (URR)-directed expression of the transforming ORFs E6 and E7, via binding to the cognate E2-binding motif Romanczuk et al., 1990) . Furthermore, both the use of somatic cell hybrids between cervical carcinoma cells and non-malignant human keratinocytes (R6sl et al., 1988 Bosch et al., 1990) and studies on partially chromosome lldeleted human fibroblasts (Smits et al., 1988 (Smits et al., , 1990 have demonstrated that alterations in the chromosomal complement of the host cell may result in profound effects on the transcriptional activity of the HPV-16/-18 URR (reviewed in zur Hausen, 1991a) . Therefore, the URR is not only the target for the virus-specific E2 transacting negative regulatory pathway, but also for a host cell control mechanism which negatively interferes with HPV expression and tumorigenicity (zur Hausen, 1986 (zur Hausen, , 1991 .
On the other hand, recent studies have shown that the transcriptional activity of HPV-16/-18 can also be controlled by cis-acting mechanisms. Integration of the conserved URR E6/E7 transcription cassette into the host genome subjects the viral DNA to cellular processes that normally affect the expression of the unoccupied gene or chromosomal domain.
By investigating the nucleosomal organization of the HPV-18 integration locus in the cervical carcinoma cell line HeLa, the location and distribution of DNase I hypersensitive sites were determined; these are known to be hallmarks for regulatory elements at the chromatin level (Elgin, 1984) . It has been shown that HPV-18 is integrated in the vicinity of a cellular promoter that cooperates with the viral URR in generating the characteristic HPV-18 transcription pattern (R6sl et al., 1989) . Moreover, depending on the chromosomal integration site in different cervical carcinoma cells, cisacting cellular regulatory elements also modify the glucocorticoid-regulated response of the HPV-18 URR (Chan et at., 1989) in a hierarchical manner, because in addition to up-regulation of viral transcription, E6/E7 expression is also found to be down-regulated or even response-refractory despite the presence of a functional hormone receptor and a corresponding binding site within the URR (von Knebel Doeberitz et al., 1991) .
Another possible cis-acting control mechanism is the modulation of the expression of foreign genes integrated into the host cell genome by de novo DNA methylation (Holliday, 1987; Doerfler, 1991) . Epigenetic modification of particular CpG residues within regulatory regions of eukaryotic genes influence the transcriptional activity, with a correlation between gene expression and hypomethylation (for review, see Razin & Cedar, 1991) . DNA methylation seems to be involved in cellular senescence (Klein et al., 1991) and genomic imprinting (Reik et al., 1987) as well as in viral latency as described recently for human immunodeficiency virus (HIV) (Bednarik et al., 1990) .
To understand the influence of DNA methylation on transcriptional regulation of HPV, we examined the effect of in vitro methylation on HPV URR-controlled reporter constructs in transient transfection assays, as well as the nucleosomal organization of methylated HPV DNA in cervical carcinoma cells. Evidence is provided that in vitro methylation selectively down-regulates HPV-18 transcription by an indirect mechanism, mediated by methyl-DNA-binding proteins. Using the MspI/HpaII isoschizomer assay on both the DNA and chromatin levels, it became apparent that methylated DNA is protected against cleavage by the methylation-insensitive enzyme MspI under in vivo conditions, suggesting that methyl-DNA-binding proteins also affect the corresponding nucleosomal organization of CpG-methylated DNA. The present study shows that epigenetic modifications of the viral DNA have an effect not only on the transcriptional competence of the regulatory region, but also on the chromatin structure of integrated DNA of pathogenic HPVs. The data indicate that viral DNA methylation is an important additional mechanism in the multi-step process of HPV-linked carcinogenesis.
Methods
Cell culture. Cells were maintained in Dulbecco's modified Eagle's medium, supplemented with 10 % fetal calf serum, 1% penicillin and 1% streptomycin.
Plasmids. pH18URR CAT contains the URR of HPV-18 cloned in pBLCAT3, a chloramphenicol acetyltransferase (CAT) construct lacking eukaryotic regulatory signals (Lukow & Schfitz, 1987) . pSV2CAT contains the complete regulatory control region of simian virus 40 (SV40) (Gorman et al., 1982) , pBLCAT2 the thymidine kinase (TK) promoter of herpes simplex virus (HSV) cloned in pBLCAT3 (Lukow & Schfitz, 1987) . pRSV-luc contains a luciferase gene expressed under the control of the Rous sarcoma virus (RSV) long terminal repeat (LTR).
In vitro methylation. Purified plasmids were treated with the corresponding methyltransferases at 37 °C for 6 to 8 h in the presence of 80 gM-S-adenosylmethionine as recommended by the suppliers. Mock-methylated controls were treated as described above, except that the enzyme was omitted. The extent of methylation as well as changes in DNA topology were monitored by digesting with HpaII or HhaI restriction endonucleases and by agarose gel analysis of the methylated DNAs in the presence of ethidium bromide (Keller, 1975) . Only completely methylated plasmids were used for DNA transfection studies.
DNA transfections and CAT assays. C33a and SiHa cervical carcinoma cell lines were transfected with methylated plasmids and the corresponding controls, together with 0.25 gg of pRSV-luc to correct the transfection efficiencies obtained using the calcium phosphate coprecipitation procedure (Wigler et al., 1978) . All transfection experiments were carried out at least four times using different preparations of CsCl-purified plasmids. The cells were harvested 48 h later by three cycles of freezing and thawing to monitor the luciferase activity (deWet et al., 1987) . The cellular extracts were standardized for the CAT assay (Gorman et al., 1982) by using equal amounts of luciferase counts. The conversion rate was determined by using a 14C scanner (Tracemaster, Linear analyser, Bertold) .
DNA and RNA analysis. Genomic DNA was prepared by standard methods (Sambrook et al., 1989) . To monitor the different methylation levels, the DNA was treated with the isoschizomeric enzymes MspI/HpaII (McClelland, 1981) as well as with the methylationsensitive enzymes HhaI and SmaI overnight at 37 °C using an enzyme:DNA ratio of 5 units:gg DNA. The digested DNAs were electrophoresed on 1% agarose gels and transferred to GeneScreen Plus filters (NEN) as described (Southern, 1975) . Total cellular RNA was isolated according to the method of Chomczynski & Sacchi (1987) , the corresponding poly(A) ÷ fraction was enriched by oligo(dT)-cellulose chromatography (Aviv & Leder, 1972) and subjected to Northern blot analysis (Khandjian & Meric, 1986) . The filters were hybridized with HPV-16/-18 DNA probes labelled by random priming (Feinberg & Vogelstein, 1984) at 42°C in the presence of 50% formamide. Washing was done at 68 °C in 2 x SSC, 0-1% SDS.
Preparation and digestion of isolated nuclei with restriction enzymes. Nuclei from cervical carcinoma cells (CaSki and SW756) were isolated under isotonic conditions using the non-ionic detergent NP40 for cell lysis (R6sl & Waldeck, 1991) . The nuclear DNA concentration was determined by the method of Lawson et al. (1980) . Nuclei equivalent to 100 gg DNA were resuspended at a concentration of 1 mg/ml in 50 mM-Tris-HC1 pH 7.5, 220 mM-sucrose, 5 mM-MgC12, 1 mM-DTT (Antequera et al., 1989) and separately digested with increasing concentrations of MspI, HpaII and HhaI (as indicated in the figure legends) for 30 min at 37 °C. The reaction was stopped by adding an equal volume of 2 % SDS, 20 mM-EDTA. After overnight incubation with proteinase K (100 pg/ml), the DNA was extracted and resuspended in TE buffer (10 mM-Tri~HC1 pH 8"0, 1 mM-EDTA).
End-labelling and gel electrophoresis. Digested genomic DNA (0.5 to 1 pg) was end-labelled by Klenow polymerase using 1 gCi [32P]dCTP in the appropriate reaction buffer (Antequera et al., 1989) for 15 min at room temperature. Non-incorporated nucleotides were removed by three consecutive cycles of ammonium acetate isopropranol precipitations. End-labelled DNA (3000 to 5000 c.p.m.) was separated on 1.8 % agarose gels. After drying of the gels on 3MM Whatman paper, the filters were exposed for autoradiography.
Results

In vitro methylation of HPV-18 URR-directed reporter constructs
In a previous study we have found that different levels of DNA methylation at the HPV-18 integration locus in HeLa cells and somatic cell hybrids derived therefrom apparently have an inverse relationship to the amount of virus-specific RNA at the steady state level detected in the cytoplasm (R6sl et al., 1988) . To investigate the epigenetic modification process on viral transcription in greater detail, we used CAT constructs harbouring the HPV-18 URR in comparison to various control plasmids for in vitro methylation experiments. As indicated in Fig.  1 , HPV-18 has nine HhaI restriction sites (5' GCGC Y, at nucleotide positions 108, 110, 1127, 7316, 7572, 7574, 7585, 7596, 7630, respectively) (Cole & Danos, 1987) . Six of them are located within the URR and clustered inside the RsaI-RsaI fragment between nucleotide positions 7508 and 7738, defined as the virus-specific enhancer region (Swift et al., 1987) .
By in vitro methylation of pH18URR-CAT plasmids using the corresponding HhaI methyltransferase, an approximately 10-fold decline of the CAT activity in comparison to the mock-treated control can be noted (Fig. 2, lanes 1 and 2) . The activity of the HPV-18 URRdirected reporter plasmid was even more reduced than in the pBLCAT2 vector (Fig. 2 , lanes 7 and 8), which harbours the TK promoter of HSV, known to be sensitive to HhaI methylase (Ben-Hattar et al., 1989).
Furthermore, & vitro methylation of every CpG residue of pH18URR-CAT using SssI methylase (Boyes & Bird, 1991) , reduces the CAT expression to the background level (Fig. 2, lane 3) .
To eliminate the possibility that the repressed CAT activity in pH18URR-CAT is due to methylation effects in non-promoter regions, several control experiments were performed. As indicated in Fig. 1 , the basic construct pBLCAT3 also possesses a certain number of HhaI restriction sites. To exclude any non-specific side effect of the cloning vector on the transcriptional activity of the inserted regulatory region, HpalI methyl- (Gorman et al., 1982) after treatment with HhaI methylase; lane 6, untreated control. Lane 7, pBLCAT2, containing the TK promoter of HSV (positions -105 to + 51) (Lukow & Schfitz, 1987) , rnethylated with HhaI methylase; lane 8, control, without any methylation. C33a cells were cotransfected with 5 pg of the corresponding plasmids together with 0.25 gg of pRSV-luc to standardize the transfection efficiencies. Cell extracts equivalent to 10000 luciferase counts were incubated for 2 h at 37 °C to monitor the CAT activity. (b) Schematic presentation of the different CAT expression levels. The plates from the thin-layer chromatography were directly measured in a 1~C scanner. The values are given relative to the [~C]chloramphenicol conversion rate of the respective untreated control, which was arbitrarily set as 100 %. CM, Chloramphenicol; AC, acetylated forms. Lanes 1 to 8 correspond directly to the different CAT assays shown in (a). The black bars represent the untreated controls.
transferase was employed. This enzyme has no recognition site within the HPV-18 U R R , but the same number of sites within pBLCAT3 as the preceding HhaI methylase (see Fig. 1 for comparison). As demonstrated in Fig. 2 , lane 4, no reduction can be detected after HpaII methyltransferase treatment. One can therefore conclude that the transcriptional down-regulation of p H 1 8 U R R -CAT is specific for the viral regulatory region, since pSV2CAT, additionally applied as a negative control for HhaI methylase (Kruczek & Doerfler, 1983 ) and containing only one HhaI site in the regulatory region of SV40, is also not significantly affected by in vitro methylation under the same experimental conditions (Fig. 2 , lanes 5 and 6). In all transfection experiments described here the HPV-negative C33a cell line was used as the recipient, but the same results were obtained in HPV-16-positive SiHa cells under both transient and stable conditions (data not shown) indicating that endogenous E6/E7 expression does not interfere with the suppressive effect of D N A methylation.
In vivo competition assays for methyl-DNA-binding proteins
Transcriptional down-regulation of the HPV-18 U R R by D N A methylation can be principally explained by two different mechanisms: the methyl moieties either directly interfere with the binding of transcription factors (Prendergast et al., 1991) or alternatively DNA-binding proteins with high affinities for methylated C p G D N A (Meehan et al., 1989) indirectly prevent a p r o t e i~D N A interaction indispensable for the formation of a functional transcription complex (Boyes & Bird, 1991) . To gain insight into this question, in vivo titration studies were performed. If there is an involvement of proteins capable of binding methylated D N A , it should be possible to compete for them by cotransfecting highly methylated non-specific prokaryotic D N A (Levine et al., 1991) together with HhaI-methylated p H 1 8 U R R -C A T reporter plasmids. This in turn should relieve the transcriptional block and allow partial reactivation of CAT expression. On the other hand, if there is merely a steric hindrance of transcription factors due to the presence of the methyl residues, the addition of increasing amounts of competitor D N A should not alleviate the methylation-mediated inhibition of the viral URR. To discriminate between these two mechanisms methylated CAT plasmids were cotransfected with SssI-methylated Bluescript DNA, keeping the total amount of prokaryotic D N A constant (10 pg) but changing the ratio of methylated and non-methylated competitor. As demonstrated in Fig. 3 , the suppressive effect on HPV-18 is indirectly mediated via the binding of proteins specific for methylated DNA, since there is indeed a partial reactivation of the CAT expression after increasing amounts of methylated untranscribable D N A were added. As shown in Fig. 3 , there is an almost fourfold increase of the CAT activity after transfection of 10 lag methylated Bluescript (BS-m) D N A in comparison to the CAT signal obtained after introduction of only 2 pg BSm together with 8 gg unmethylated (BS-u) control DNA.
These findings led to the conclusion that the suppressive effect o f D N A methylation on the HPV-18 U R R is mediated indirectly by the binding of titratable methyl- CpG-binding proteins (MeCPs) (Meehan et al., 1989) . In order to generalize these results, we subsequently determined whether endogenous methylated HPV DNA, integrated into the chromosomal DNA of the host cell, might also be associated with MeCPs on the basis of the accessibility to restriction enzymes on native chromatin in comparison to digestion products at the DNA level (Antequera et al., 1989 (Antequera et al., , 1990 ).
Viral DNA methylation pattern in cervical carcinoma cells and susceptibility of nucleosomally organized methylated DNA to restriction enzyme digestion
To answer this question we first screened all available cervical carcinoma cell lines for the presence of methylated HPV DNA using the MspI/HpaII isoschizomer assay (McCMland, 1981) . This approach is based on the fact that both restriction endonucleases cleave the same recognition site (5' CCGG 3'). MspI cuts regardless of the degree of methylation, whereas HpaII cannot digest the DNA at this position when the inner cytosine is methylated. In this way a ladder of partially cleaved DNA fragments is created, which migrate as off-size bands and are not present in the corresponding MspI control. Using this strategy, it was found that the cervical carcinoma cell line CaSki, which contains approximately 600 copies of HPV-16 (Baker et al., 1987) , has the highest degree of viral DNA methylation. As demonstrated in The same degree of methylation can be also detected using other methylation-sensitive enzymes, such as HhaI (lane 3) or Sinai (lane 4). Although CaSki cells contain a high copy number of HPV-16 DNA, the virus-specific mRNA is poorly expressed and only reliably detectable by Northern blot analysis after poly(A) + selection (Fig. 4a, lane 1) . Treatment of the cells with the protein synthesis inhibitor cycloheximide (CHX) is not accompanied by an increase of the signal (lane 2) favouring the interpretation that the low transcriptional activity might be due to extensive DNA methylation rather than to trans-repressing CHXlabile proteins. Since DNA methylation promotes the nucleosomal assembly into a configuration characteristic of a heterochromatin structure (Keshet et al., 1986; Buschhausen et al., 1987) , we used CaSki cells (together with HPV-18-positive SW 756 cervical carcinoma cells, see below) as a model to study the chromatin structure in terms of accessibility to MspI and other methylationsensitive restriction enzymes. If the in vivo situation is the same as that detected by the titration assay described above, one might predict that methylation-binding proteins should protect nucleosomally organized methylated DNA from cleavage by MspI, which normally cleaves protein-free DNA independently of the degree of methylation (see Fig. 4b, lane 1, for comparison) .
Isotonic nuclei from CaSki cells were prepared, digested with increasing amounts of MspI, HpaII and HhaI endonucleases and the cleavage patterns were compared with those of purified DNA. Fig. 5 (a) shows the effect of MspI (lanes 2 to 4) on the accessibility of bulk cellular chromatin. In contrast to HpalI (lanes 5 to 7) and HhaI (lanes 8 to 10), increasing amounts of MspI induce a slight smear after electrophoretic separation of purified DNA; this can mainly be attributed to the higher cleavage efficiency of the enzyme owing to its insensitivity to DNA methylation. Since MspI and HpaII (but not HhaI) produce 3'-OH sticky ends, the accessibility of the cellular chromatin to a methylationinsensitive (MspI) and a methylation-sensitive (HpaII) restriction endonuclease can be directly compared by end-labelling the digestion products using Klenow polymerase and [32P]dCTP. Lane 1 (b) shows the untreated control, which represents the DNA from nuclei incubated in the corresponding digestion buffer without any restriction endonuclease. Lanes 2 to 4 reveal the end-labelled probes after MspI digestion, lanes 5 to 7 those after HpaII treatment, where ladders of single and multiple copies of the nucleosomal repeat are accumulated.
To monitor the nuclease accessibility of nucleosomally organized HPV-16 DNA, the probes were restricted with the viral non-cutting enzyme HindIII and hybridized with unit-length viral DNA. Fig. 5 (c) allows a direct . By monitoring the effect of increasing amounts of MspI on viral chromatin (lanes 3 to 6), essentially the same situation is revealed as shown in the previous experiment using CaSki nuclei as the substrate. The prominent 6"8 kb off-size fragment detected after HpalI digestion at the D N A level (lane 8) is also visible after MspI cleavage of native chromatin (lanes 3 to 6), again indicating that methylated 5' C C G G 3' sites in nuclei are protected against MspI digestion. Also of interest is the finding that the treatment of isotonic SW 756 nuclei with HhaI endonuclease (Fig. 6b ) results in the same cleavage pattern in native chromatin (lanes 2 to 5), which is also detectable for purified D N A (lane 6), strongly suggesting that the corresponding HhaI recognition sites are not associated with nucleosomes. (Fig. 6) . Here, the viral DNA is not so
D i s c u s s i o n
Comparative studies have demonstrated a close functional correlation between D N A methylation and gene regulation in eukaryotic cells (for review, see Razin & Cedar, 1991) . Not only endogenous genes are subjected to this kind of epigenetic modifications but also certain human DNA tumour viruses such as EpsteimBarr virus (Masucci et al., 1989) and the hepatitis B virus (Korba et al., 1985) which take advantage of this host cell control mechanism as a regulatory pathway to modulate virusspecific gene expression at the transcriptional level. In the present investigation, evidence is provided that the activity of the U R R of pathogenic HPV-18 can also be altered by DNA methylation. Sequence-specific in vitro methylation by using HhaI methyltransferase results in a significant down-regulation of CAT expression in HPV-18 URR-controlled reporter plasmids (Fig. 2) , which seems to be specific for several HhaI acceptor sites within the viral control region (see Fig. 1 ). In contrast, HpaII methylase, which has no recognition sites in the HPV-18 U R R but the same number of acceptor sites as HhaI methylase within the basic vector, has no effect on CAT expression (Fig. 2, lane 4) . This suggests that the suppressive effect is not region- (Murray & Grosveld, 1987) but sequence-specific, depending on a non-random distribution of six HhaI sites enriched in the viral control region and of which five are located within the constitutive enhancer element (Swift et al., 1987) . This is in accordance with other studies (Boyes & Bird, 1992) also showing that the density of methylated CpG sites is an important parameter for the degree of repression at particular regulatory regions.
The application of sequence-specific methyltransferases, however, is often limited, because further CpG dinucleotides, normally representing targets for the eukaryotic methylase (Rachal et al., 1989) , cannot be reached unless they are embedded in a corresponding recognition site. Inspection of the HPV-18 sequence reveals that the regulatory region has 20 CpG dinucleotides among which only 11 coincide with HhaI methylase acceptor sites. Another stretch of five CpGs is located near the TATA box within the palindromic sequence of the E2-binding site [5' ACCG(A)~CGGT-CGGG-ACCG(A)4CGGT 3'] (Romanczuk et al., 1990) . The use of SssI methylase (Boyes & Bird, 1991) , which mimics the activity of the eukaryotic counterpart in methylating CpG residues, completely abolishes the activity of the HPV-18 URR-driven reporter construct, emphasizing the functional significance of these sites in the transcriptional competence of the regulatory region. The effect of SssI in vitro methylation can be considered to be specific for the viral URR, since it has been reported that the same basic vector harbouring the LTR of RSV as a regulatory insert results in only a twofold reduction after general CpG methylation (Rachal et aI., 1989) . A possible explanation is that the strong enhancer configuration of the RSV LTR appears to be sufficient to overcome the methylation-imposed repression effect (Knebel-M6rsdorf et al., 1988; Boyes & Bird, 1991) . Mutational dissection of the HPV-18 URR in its natural context (Hoppe-Seyler & Butz, 1993) in parallel with in vitro methylation studies should clarify the role of the CpG cluster at this position.
A compilation of experiments analysing the mechanism of gene repression by DNA methylation has shown that methylated DNA becomes assembled in the nucleus into a nucleosomal conformation which is reminiscent of transcriptionally inactive chromatin (Keshet et al., 1986; Buschhausen et aI., 1987) . Furthermore, recent studies have described different classes of DNA-binding proteins with high affinity for methylated DNA, which are distinguishable by their binding specificities. While the methylated DNA-binding protein requires additional recognition sequences surrounding the methylated CpG site (Zhang et al., 1989) , the properties of MeCP can be regarded as non-specific, depending only on a symmetrical distribution of a certain number of methylated CpG residues (Meehan et al., 1989) . Since HhaI in vitro methylated pHP18URR-CAT expression vectors can be reactivated by cotransfection of increasing amounts of SssI methylasetreated untranscribable prokaryotic DNA, this result strongly indicates the involvement of the latter class of methyl-DNA-binding proteins in the repression mechanism of the HPV-18 regulatory region (Fig. 3) . Moreover, reactivation by in vitro titration also supports the notion that the chromatin structure cannot solely account for the transcriptional down-regulation of in vitro methylated plasmids. The MeCPs might function either as stabilizing components of the nucleoprotein complex (Antequera et al., 1989) or as phasing proteins on methylated CpG residues during the process of assembly into a nucleosomal composition typical of transcriptionally inactive chromatin (Meehan et al., 1989) . Although the first possibility cannot be ruled out conclusively at the moment, the results obtained by the restriction enzyme accessibility assays of cervical carcinoma cells rather favour the assumption that MeCPs are involved in the process of positioning nucleosomes on methylated DNA templates into a heterochromatin conformation.
The analysis of susceptible or protected regions in native chromatin is thought to be determined mainly by two parameters. Recognition sites coinciding with condensed chromatin domains or with nucleosomal core regions are resistant, whereas linker regions in transcribed stretches or nuclease-hypersensitive sites are vulnerable to restriction enzyme digestion (Almer & H6rz, 1986) . As already shown for endogenous genes (Antequera et al., 1989) , MspI endonuclease, normally cleaving purified DNA whether methylated or not, is unable to cut the corresponding HPV-16/-18 sequences if the DNA is organized as chromatin ( Fig. 5 and 6 ). The MspI fragment pattern is similar or even identical to the cleavage products obtained after HpaII digestion at the DNA level, implying that methylated recognition sites are protected under in vivo conditions. Since it is unlikely that every methylated CpG site in both investigated cell lines consistently coincides with a nucleosomal core region, the resistance can be explained either by the assumption that the MeCP binding pattern is retained even after integration of viral DNA, or a supranucleosomal structure is assembled which is not accessible to exogenously added nucleases.
The role of DNA methylation in HPV-linked carcinogenesis can be considered in the context that viral integration into the host genome seems to be an early event during the different progression steps to anogenital cancer (Schneider-Maunoury et aI., 1987; zur Hausen, 1991b) . Consequently, the viral DNA is subjected to epigenetic modification mechanisms which would normally affect the expression of the unoccupied chromosomal domain. MspI/HpaII isoschizomer assays on both premalignant and malignant biopsy material have revealed that episomal HPV DNA is not methylated, but is found to be methylated if integrated (F. R6sl & H. zur Hausen, unpublished results) . It is therefore reasonable to assume that integrated HPV-18 DNA can potentially be methylated de novo at the same positions shown to be sensitive to HhaI or SssI methyltransferases under in vitro conditions. This could result in viral latency caused by negative interference with HPV gene expression, which is reminiscent of conditions described for Moloney murine leukaemia virus in mice (Jfihner & Jaenisch, 1985) or for HIV in human cells (Bednarik et al., 1990) . A possibly analogous system is found in transgenic mice carrying integrated SV40 DNA. Here, the viral DNA was found to be demethylated exclusively in tumorigenic cells, but hypermethylated in non-malignant tissues (Van Dyke et al., 1985) suggesting that a decrease in methylation maintenance is either the cause or a consequence of cellular transformation (Feinberg & Vogelstein, 1983) . Consistent with this interpretation is the finding that bovine papillomavirus DNA also shows a reduced transforming potential after in vitro methylation and transfection into heterologous rodent cells (Christy & Scangos, 1986) .
A detailed comparison of the methylation levels of HPV-16/-18 DNA in premalignant and malignant lesions in relation to viral transcription should provide insight into the role of viral methylation in the different steps leading to cervical cancer. Moreover, the utilization of cell lines containing integrated HhaI methylasesuppressed HPV-18 URR-CAT reporter constructs should be helpful in clarifying the question of whether certain carcinogens, known to induce hypomethylation (Wilson et al., 1987; Barr et al., 1992) and considered to be cofactors in HPV-linked carcinogenesis (zur Hausen, 1991 b), are capable of overcoming methylation-imposed repression. A cell system could thus be developed which should allow the screening and identification of substances that may act in an either additive or synergistic manner with HPV infection.
